BARD1 and breast carcinoma: This was excellently demonstrated in Sato et al.’s use of FLAG-labeled ubiquitin to identify targets of the heterodimeric E3 ligase BRCA1-BARD1 (breast cancer 1, early onset BRCA1 associated RING domain)32.